Business Context and Reporting Period
This Form 8-K is filed by Neuralstem, Inc. (not Palisade Bio, Inc.) on August 13, 2009, reporting events occurring on August 7, 2009. The filing addresses the Company's financial results for the three and six months ended June 30, 2009, and a regulatory notice regarding its listing status on the NYSE Amex.
Key Financial Metrics
The filing references a press release (Exhibit 99.1) containing results for the three and six months ended June 30, 2009. However, the text of this 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release for these figures.
Material Changes and Regulatory Status
- Listing Compliance Warning: On August 7, 2009, the Company received a Warning Letter from the NYSE Amex for failing to comply with Section 301 of the Company Guide.
- Violation Details: The Company issued additional securities in a June 30, 2009 offering without first receiving Exchange approval for the listing of those securities.
- Remediation: The Company submitted an application for the additional listing of securities on July 31, 2009. Approval of this application is expected to remedy the deficiency.
Guidance, Outlook, and Risks
The filing does not contain specific forward-looking guidance, management commentary on future operations, or a detailed risk factor analysis beyond the immediate listing compliance issue. The primary risk highlighted is the potential impact of the listing deficiency on the Company's ability to trade on the NYSE Amex until the application is approved.
Investor Verification Checklist
- Verify the specific financial results (revenue, net loss, cash position) by reviewing the attached Press Release (Exhibit 99.1).
- Confirm the current status of the July 31, 2009 listing application with the NYSE Amex to ensure the Warning Letter has been resolved.
- Review the June 30, 2009 offering details to understand the volume of securities issued without prior listing approval.
- Check for any subsequent filings regarding the Company's continued listing status or potential delisting proceedings.